BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 3165372)

  • 1. Gradient fractionation of cycling and resting cells monitored by BrdUrd incorporation.
    Papa S; Vitale M; Mazzotti G; Rizzoli R; Falconi M; Bartoletti A; Manzoli FA
    Histochemistry; 1988; 89(3):241-5. PubMed ID: 3165372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bromodeoxyuridine/DNA analysis of replication in CHO cells after exposure to UV light.
    Hoy CA; Carswell C; Schimke RT
    Mutat Res; 1993 Dec; 290(2):217-30. PubMed ID: 7694113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flow cytometric measurement of cell cycle kinetics in rat Walker-256 carcinoma following in vivo and in vitro pulse labelling with bromodeoxyuridine.
    Fogt F; Wan J; O'Hara C; Bistrian BR; Blackburn GL; Istfan NW
    Cytometry; 1991; 12(1):33-41. PubMed ID: 1825629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiation of mitotic melanoma cells from G2 cells and their isolation by use of 5-bromo-2'-deoxyuridine and propidium iodide.
    Trinkle LS; Swope VB; Abdel-Malek ZA; Nordlund JJ
    Cytometry; 1988 Sep; 9(5):432-5. PubMed ID: 3180943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discrimination of bromodeoxyuridine labelled and unlabelled mitotic cells in flow cytometric bromodeoxyuridine/DNA analysis.
    Jensen PO; Larsen JK; Christensen IJ; van Erp PE
    Cytometry; 1994 Feb; 15(2):154-61. PubMed ID: 8168402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluorescence enhancement of DNA-bound TO-PRO-3 by incorporation of bromodeoxyuridine to monitor cell cycle kinetics.
    Beisker W; Weller-Mewe EM; Nüsse M
    Cytometry; 1999 Nov; 37(3):221-9. PubMed ID: 10520203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of resting cells by dual-parameter flow cytometry of statin expression and DNA content.
    Pellicciari C; Mangiarotti R; Bottone MG; Danova M; Wang E
    Cytometry; 1995 Dec; 21(4):329-37. PubMed ID: 8608730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bromodeoxyuridine enhancement of 1-beta-D-arabinofuranosylcytosine metabolic activation and toxicity in HL-60 leukemic cells.
    Ross DD; Joneckis CC; Song TH; Wu RK
    Cancer Res; 1988 Feb; 48(3):517-21. PubMed ID: 3335018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Separation by counterflow centrifugal elutriation and analysis of T- and B-lymphocytic cell lines in progressive stages of cell division cycle.
    Donaldson KL; McShea A; Wahl AF
    J Immunol Methods; 1997 Apr; 203(1):25-33. PubMed ID: 9134027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flow cytometric estimation of cell cycle parameters using a monoclonal antibody to bromodeoxyuridine.
    Sasaki K; Murakami T; Ogino T; Takahashi M; Kawasaki S
    Cytometry; 1986 Jul; 7(4):391-5. PubMed ID: 3089742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved bromodeoxyuridine/DNA analysis by anti-BudR monoclonal antibody versus right angle light scatter.
    Vitale M; Neri LM; Manzoli L; Galanzi A; Rana R; Antonucci A; Papa S
    Histochemistry; 1989; 93(1):9-11. PubMed ID: 2613552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunofluorescent evaluation of DNA repair synthesis using interactive laser cytometry.
    Srivastava V; Miller S; Busbee D
    Cytometry; 1993; 14(2):144-53. PubMed ID: 8440148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of denaturation with HCl on the immunological staining of bromodeoxyuridine incorporated into DNA.
    Sasaki K; Adachi S; Yamamoto T; Murakami T; Tanaka K; Takahashi M
    Cytometry; 1988 Jan; 9(1):93-6. PubMed ID: 2457476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of bromodeoxyuridine incorporation measurements to the determination of cell distribution within the S phase of the cell cycle.
    Khochbin S; Chabanas A; Albert P; Albert J; Lawrence JJ
    Cytometry; 1988 Sep; 9(5):499-503. PubMed ID: 3180952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinction between 5-bromodeoxyuridine labeled and unlabeled mitotic cells by flow cytometry.
    Darzynkiewicz Z; Traganos F; Melamed MR
    Cytometry; 1983 Mar; 3(5):345-8. PubMed ID: 6839883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokinetic analysis of lung cancer by bromodeoxyuridine labeling of cytology specimens.
    ten Velde GP; Schutte B; Reijnders MM; Bosman FT; Blijham GH
    Cytometry; 1989 Nov; 10(6):807-10. PubMed ID: 2582973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Flow cytometric dual-parameter analysis of human leukemic cells using monoclonal anti-BrdUrd antibody].
    Sasaki K; Murakami T; Ogino T; Takahashi M
    Gan No Rinsho; 1985 May; 31(5):549-51. PubMed ID: 3860667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of methotrexate on cell cycle and DNA synthesis of astrocytes in primary culture: flow cytometric studies.
    Bruce-Gregorios JH; Soucy D; Chen MG; Benson N
    J Neuropathol Exp Neurol; 1991 Jan; 50(1):63-72. PubMed ID: 1985154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transient inhibition of initiation of S-phase associated with dimethyl sulfoxide induction of murine erythroleukemia cells to erythroid differentiation.
    Terada M; Fried J; Nudel U; Rifkind RA; Marks PA
    Proc Natl Acad Sci U S A; 1977 Jan; 74(1):248-52. PubMed ID: 64982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flow cytometric detection of mitotic cells using the bromodeoxyuridine/DNA technique in combination with 90 degrees and forward scatter measurements.
    Nüsse M; Jülch M; Geido E; Bruno S; Di Vinci A; Giaretti W; Ruoss K
    Cytometry; 1989 May; 10(3):312-9. PubMed ID: 2496957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.